Pilot Projects Core
试点项目核心
基本信息
- 批准号:7701548
- 负责人:
- 金额:$ 25.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:CategoriesCellular ImmunityCommunitiesDevelopmentFacultyFosteringFundingGoalsHumanImmunologyNational Institute of Allergy and Infectious DiseasePilot ProjectsPublicationsResearchResearch PersonnelResearch Project GrantsSecureSeedsStagingVirusbiodefensecareer developmentimprovedinnovationprogramssuccessvirology
项目摘要
The Pilot Projects Core will support new research initiatives during the formative stage by providing
"seed" funding to small, short-term (1-2 year) pilot research projects selected through competitive review.
Applications will be solicited from the general UMMS scientific community and their collaborators and will be
reviewed by a panel of senior UMMS faculty investigators from the Program in Immunology and Virology.
The goals of the Core will be to facilitate the entry of new investigators into the biodefense research
field and improve the competitiveness of projects for external funding. Success of the program will be
evaluated through review of the record of publications and success at securing external funding. The Pilot
Projects program is expected to foster innovation and career development, aiding the overall objectives of
the CTRHIB and the NIAID biodefense research program.
先导计划核心项目将在新的研究计划形成阶段提供支援,
向通过竞争性审查选定的小型短期(1-2年)试验研究项目提供“种子”资金。
申请将征求一般UMMS科学界和他们的合作者,并将
由来自免疫学和病毒学项目的高级UMMS教师调查小组审查。
核心的目标将是促进新的调查人员进入生物防御研究
外地和提高项目的竞争力,争取外部资金。该计划的成功将是
通过审查出版物记录和获得外部资金的成功情况进行评价。试点
项目计划预计将促进创新和职业发展,帮助实现
CTRHIB和NIAID生物防御研究计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan L Rothman其他文献
A Plasmid-based Reporter System for Live Cell Imaging of Dengue Infected Cells Citation/publisher Attribution a Plasmid-based Reporter System for Live Cell Imaging of Dengue Infected Cells. 1 Running Title: Live Cell Imaging of Dengue Virus Infection 2 3
用于登革热感染细胞活细胞成像的基于质粒的报告系统 引文/出版商归属 用于登革热感染细胞活细胞成像的基于质粒的报告系统。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Carey L. Medin;Sierra Valois;Chinmay G. Patkar;Alan L Rothman;Alan L Rothman - 通讯作者:
Alan L Rothman
Alan L Rothman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan L Rothman', 18)}}的其他基金
Elimination of flavivirus infected target cells by ADCC
通过 ADCC 消除黄病毒感染的靶细胞
- 批准号:
10170256 - 财政年份:2020
- 资助金额:
$ 25.73万 - 项目类别:
Elimination of flavivirus infected target cells by ADCC
通过 ADCC 消除黄病毒感染的靶细胞
- 批准号:
10057300 - 财政年份:2020
- 资助金额:
$ 25.73万 - 项目类别:
Immune-Based Interventions Against Infectious Diseases
针对传染病的免疫干预措施
- 批准号:
8432209 - 财政年份:2013
- 资助金额:
$ 25.73万 - 项目类别:
Immune-Based Interventions Against Infectious Diseases
针对传染病的免疫干预措施
- 批准号:
9275512 - 财政年份:2013
- 资助金额:
$ 25.73万 - 项目类别:
Immune-Based Interventions Against Infectious Diseases
针对传染病的免疫干预措施
- 批准号:
8727073 - 财政年份:2013
- 资助金额:
$ 25.73万 - 项目类别:
相似海外基金
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
- 批准号:
22K09932 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10508093 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10501418 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10650823 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10449406 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10797812 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10662571 - 财政年份:2022
- 资助金额:
$ 25.73万 - 项目类别:














{{item.name}}会员




